Brief: AB Science: New Independent Publication Confirms Role Of Masitinib As Potential Therapy In Pancreatic Cancer

AB Science SA

23/02/2021 07:11

Feb 23 (Reuters) - AB Science SA  ABS.PA :
    * REG-AB SCIENCE ANNOUNCES THAT A NEW INDEPENDENT
PUBLICATION
CONFIRMS THE ROLE OF MASITINIB AS A POTENTIAL THERAPY IN
PANCREATIC CANCER
    * VARIOUS MARKERS OF MAST CELL ACTIVITY WERE INCREASED IN
PANCREATIC DUCTAL ADENOCARCINOMA TISSUE AS COMPARED WITH
ADJACENT NORMAL TISSUE
    * MAST CELLS ARE STRONGLY ASSOCIATED WITH ANGIOGENESIS IN
PANCREATIC CANCER TISSUE
    * DENSITY OF MAST CELLS POSITIVE FOR TRYPTASE (MCDPT) AND
AREA OF
MAST CELLS POSITIVE FOR TRYPTASE (MCAPT) ARE TISSUE BIOMARKERS
THAT COULD BE PREDICTIVE OF RESPONSE TO MASITINIB (ANTI‐C‐KIT
THERAPY)

Source text for Eikon:  ID:nGNE69mfSF 
Further company coverage:  ABS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))